Publications
Original Article
Identification and Validation of Th1-Selective Epitopes Derived from Proteins Overexpressed in Breast Cancer Stem Cells
Cancer Vaccines
2025
Authors:
Denise L. Cecil, Daniel Herendeen, Meredith Slota, Megan M. O’Meara, Yushe Dang, Lauren Corulli, and Mary L. DisisORCID
Journal:
Vaccines
Volume:
13(5)
Page:
525
Pubmed:
Original Article
Intraperitoneal immunotherapy with denileukin diftitox (ONTAK) in recurrent refractory ovarian cancer
Clinical Trials
2024
Authors:
John B Liao, Nikita S Jejurikar, Katie M Hitchcock-Bernhardt, William R Gwin, Jessica L Reichow, Yushe Dang, Jennifer S Childs, Andrew L Coveler, Ron E Swensen, Barbara A Goff, Mary L Disis, Lupe G Salazar
Journal:
Gynecologic Oncology
Volume:
191
Page:
74-79
Pubmed:
Original Article
A Phase I/II Trial of HER2 Vaccine-Primed Autologous T-Cell Infusions in Patients with Treatment Refractory HER2-Overexpressing Breast Cancer
Clinical Trials
2023
Authors:
Disis ML, Dang Y, Coveler AL, Childs JS, Higgins DM, Liu Y, Zhou J, Mackay S, Salazar LG
Journal:
Clinical Cancer Research
Volume:
29(17)
Page:
3362-3371
Pubmed:
Original Article
Anti-tumor activity of a T-helper 1 multiantigen vaccine in a murine model of prostate cancer
Cancer Vaccines
2022
Authors:
Cecil, D.L., Curtis, B, Gad, E., Gormley, M, Timms, A.E., Corulli, L., Bos, R., Damle, R.N., Sepulveda, M.A., and Disis, M.L.
Journal:
Scientific Reports
Volume:
12
Page:
13618
Pubmed:
Original Article
COX-2 Inhibitors Decrease Expression of PD-L1 in Colon Tumors and Increase the Influx of Type I Tumor-infiltrating Lymphocytes
Cancer Vaccines
2022
Authors:
Cecil DL, Gad EA, Corulli LR, Drovetto N, Lubet RA, Disis ML
Journal:
Cancer Prevention Research
Volume:
15(4)
Page:
225-231
Pubmed:
Original Article
Unexpected Liver and Kidney Pathology in C57BL/6J Mice Fed a High-fat Diet and Given Azoxymethane to Induce Colon Cancer
Cancer Vaccines
2022
Authors:
Waggie, KS, Corulli, LR, Cecil, D, Rodmaker, ER, Walsh, C, and Disis, ML
Journal:
Comparative Medicine
Volume:
72(5)
Page:
330-335
Pubmed:
Original Article
Safety and Outcomes of a Plasmid DNA Vaccine Encoding the ERBB2 Intracellular Domain in Patients With Advanced-Stage ERBB2-Positive Breast Cancer
Clinical Trials
2022
Authors:
Disis, ML, Guthrie, KA, Liu, Y, Coveler, AL, Higgins, DM, Childs, JS, Dang, Y, and Salazar, LG
Journal:
JAMA Oncology
Volume:
9(1)
Page:
71-78
Pubmed:
Original Article
Tumor-associated autoantibodies from mouse breast cancer models are found in serum of breast cancer patients
2021
Authors:
Stanton, SE, Gad E, Ramos, E, Corulli LR, Annis, J, Katayama, H, Hamash S and Disis, ML
Journal:
Nature Partner Journals Breast Cancer
Volume:
7(1)
Page:
50
Pubmed:
Original Article
Pembrolizumab with low-dose carboplatin for recurrent platinum-resistant ovarian, fallopian tube, and primary peritoneal cancer: survival and immune correlates
Clinical Trials
2021
Authors:
John B Liao, William R Gwin, Renata R Urban, Katie M Hitchcock-Bernhardt, Andrew L Coveler, Doreen M Higgins, Jennifer S Childs, Hania N Shakalia, Ron E Swensen, Sasha E Stanton, Anna V Tinker, Tanya A Wahl, Richard G Ancheta, Kathryn F McGonigle, James Y Dai, Mary L Disis, Barbara A Goff
Journal:
Journal for ImmunoTherapy of Cancer
Volume:
9(9)
Page:
Pubmed:
Original Article
Multi-Epitope-Based Vaccines for Colon Cancer Treatment and Prevention
Cancer Vaccines
2021
Authors:
Corulli LR, Cecil DL, Gad E, Koehnlein M, Coveler AL, Childs JS, Lubet RA, Disis ML.
Journal:
Frontiers in Immunology
Volume:
12
Page:
Pubmed: